I Like Peloton to Keep Rolling in 2021, and Planet Fitness Might Be a Buy, Too

The former name is technically overbought but offers reasons to expect it to grow, while the latter should benefit from the Covid-19 vaccines.

Let's Put COMPASS Pathways in the Watch but Not Act Yet Category

CMPS may be a company representing the true cannabis 2.0. The irony in that is it isn't a cannabis company but rather a play on psilocybin.

A Technical Update on Halozyme Therapeutics

Let's review the charts and indicators.

McKesson's Rally Has Further to Go

The shares have been digesting and consolidating the gains achieved in early November.

What the Charts Say About Veeva Systems Stock

Our latest analysis and trading strategy for the cloud healthcare software provider.

Top 5 Asian Healthcare Stocks for 2021

Here are five picks in a sector whose private- and public-sector support is sure to continue as Asia ages.

HCA Healthcare's Technical Strategy and Price Targets Are Positive

The charts are generally bullish and HCA could head up towards $200, but there are some caveats.

Hain Celestial's Base Could Support Further Price Gains

The shares have doubled from their March nadir.

The Pullback in Alphatec Should Offer a Strong Entry on Thursday's Breakout

My preference here is to target an option that will work more like a stock replacement approach.

Telehealth Isn't Just for People Anymore

A look at the fast-growing field of telehealth, both for people and, as a less-well known market, for pets.